Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)
R&D to Revenue
6.04%
Quarterly · Period ending:
TEVA R&D to Revenue
Latest reported6.04%period ending
Latest reported6.04%period ending
TEVA Quarterly R&D/Revenue (0.00% → 6.04%)
Latest values, visible window
High-resolution chart · PNG
TEVA r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 5.2801% | |
| 5.7031% | |
| 5.9251% | |
| 6.1415% | |
| 5.9217% | |
| 5.906% | |
| 5.7493% | |
| 6.104% | |
| 7.2523% | |
| 6.6759% | |
| 5.3553% | |
| 6.693% | |
| 6.5561% | |
| 5.8451% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |